131 related articles for article (PubMed ID: 1623518)
1. Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation.
Lu X; Park SH; Thompson TC; Lane DP
Cell; 1992 Jul; 70(1):153-61. PubMed ID: 1623518
[TBL] [Abstract][Full Text] [Related]
2. Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.
Thompson TC; Park SH; Timme TL; Ren C; Eastham JA; Donehower LA; Bradley A; Kadmon D; Yang G
Oncogene; 1995 Mar; 10(5):869-79. PubMed ID: 7534899
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
Watanabe H; Shimokado K; Asahara T; Dohi K; Niwa O
Jpn J Cancer Res; 1999 Jan; 90(1):40-7. PubMed ID: 10076563
[TBL] [Abstract][Full Text] [Related]
5. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
6. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
[TBL] [Abstract][Full Text] [Related]
8. Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu D; Michalovitz D; Eliyahu S; Pinhasi-Kimhi O; Oren M
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8763-7. PubMed ID: 2530586
[TBL] [Abstract][Full Text] [Related]
9. Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.
Merz VW; Miller GJ; Krebs T; Timme TL; Kadmon D; Park SH; Egawa S; Scardino PT; Thompson TC
Mol Endocrinol; 1991 Apr; 5(4):503-13. PubMed ID: 1922083
[TBL] [Abstract][Full Text] [Related]
10. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
11. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients.
Pelisson I; Soler C; Chardonnet Y; Euvrard S; Schmitt D
Cancer Detect Prev; 1996; 20(1):20-30. PubMed ID: 8907200
[TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.
Thompson TC; Timme TL; Kadmon D; Park SH; Egawa S; Yoshida K
Mol Carcinog; 1993; 7(3):165-79. PubMed ID: 8489712
[TBL] [Abstract][Full Text] [Related]
13. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination.
Taylor WR; Egan SE; Mowat M; Greenberg AH; Wright JA
Oncogene; 1992 Jul; 7(7):1383-90. PubMed ID: 1620551
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
[TBL] [Abstract][Full Text] [Related]
15. Direct transactivation of c-Ha-Ras gene by p53: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis.
Deguin-Chambon V; Vacher M; Jullien M; May E; Bourdon JC
Oncogene; 2000 Nov; 19(51):5831-41. PubMed ID: 11127813
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.
Greene DR; Taylor SR; Aihara M; Yoshida K; Egawa S; Park SH; Timme TL; Yang G; Scardino PT; Thompson TC
Int J Cancer; 1995 Jan; 60(3):395-9. PubMed ID: 7829250
[TBL] [Abstract][Full Text] [Related]
17. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
[TBL] [Abstract][Full Text] [Related]
18. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells.
Chen TM; Defendi V
Oncogene; 1992 Aug; 7(8):1541-7. PubMed ID: 1321402
[TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
